{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:14:06Z","timestamp":1790738046114,"version":"4.1.0"},"reference-count":30,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3201\/eid2010.140411","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T12:58:00Z","timestamp":1408971480000},"page":"1629-1636","source":"Crossref","is-referenced-by-count":31,"title":["Effects of Mefloquine Use on\n                    <i>Plasmodium vivax<\/i>\n                    Multidrug Resistance"],"prefix":"10.3201","volume":"20","author":[{"given":"Nimol","family":"Khim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voahangy","family":"Andrianaranjaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Popovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saorin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsene","family":"Ratsimbasoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Barnadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Thellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Musset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Menegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakri Y.M.","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Tichit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Bouchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Mercereau-Puijalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2010.140411-201409110919-R1","doi-asserted-by":"crossref","unstructured":"Meshnick S, Dobson M. The history of antimalarial drugs. Totowa (NJ): Humana Press; 2001.","DOI":"10.1385\/1-59259-111-6:15"},{"key":"key-10.3201\/eid2010.140411-201409110919-R2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","article-title":"Epidemiology of drug-resistant malaria.","volume":"2","author":"Wongsrichanalai","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2010.140411-201409110919-R3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0163-7258(91)90074-V","article-title":"The dynamics of drug resistance in Plasmodium falciparum.","volume":"50","author":"Wernsdorfer","year":"1991","journal-title":"Pharmacol Ther"},{"key":"key-10.3201\/eid2010.140411-201409110919-R4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","article-title":"The public health impact of chloroquine resistance in Africa.","volume":"64","author":"Trape","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(81)92239-X","article-title":"Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.","volume":"1","author":"Hurwitz","year":"1981","journal-title":"Lancet"},{"key":"key-10.3201\/eid2010.140411-201409110919-R6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","article-title":"Spread and evolution of Plasmodium falciparum drug resistance.","volume":"58","author":"Mita","year":"2009","journal-title":"Parasitol Int"},{"key":"key-10.3201\/eid2010.140411-201409110919-R7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pt.2007.03.002","article-title":"Antifolates can have a role in the treatment of Plasmodium vivax.","volume":"23","author":"Hawkins","year":"2007","journal-title":"Trends Parasitol"},{"key":"key-10.3201\/eid2010.140411-201409110919-R8","first-page":"27","article-title":"Pyrimethamine resistance in Plasmodium vivax malaria.","volume":"20","author":"Young","year":"1959","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid2010.140411-201409110919-R9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4269\/ajtmh.2001.65.588","article-title":"Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria.","volume":"65","author":"Mayxay","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pt.2004.03.006","article-title":"Mixed-species malaria infections in humans.","volume":"20","author":"Mayxay","year":"2004","journal-title":"Trends Parasitol"},{"key":"key-10.3201\/eid2010.140411-201409110919-R11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pt.2004.05.004","article-title":"The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.","volume":"20","author":"Snounou","year":"2004","journal-title":"Trends Parasitol"},{"key":"key-10.3201\/eid2010.140411-201409110919-R12","unstructured":"World Health Organization. World malaria report 2012 [cited 25 Jul 2014]. http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/"},{"key":"key-10.3201\/eid2010.140411-201409110919-R13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine.","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2010.140411-201409110919-R14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1994.51.648","article-title":"A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro.","volume":"51","author":"Peel","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R15","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2010.140411-201409110919-R16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid2010.140411-201409110919-R17","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/AAC.01459-07","article-title":"Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar.","volume":"52","author":"Imwong","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2010.140411-201409110919-R18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.4269\/ajtmh.12-0701","article-title":"Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.","volume":"88","author":"Lin","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R19","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/592451","article-title":"Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.","volume":"198","author":"Suwanarusk","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2010.140411-201409110919-R20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1475-2875-10-376","article-title":"Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.","volume":"10","author":"Jovel","year":"2011","journal-title":"Malar J"},{"key":"key-10.3201\/eid2010.140411-201409110919-R21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4269\/ajtmh.2012.12-0094","article-title":"Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns.","volume":"87","author":"Vargas-Rodr\u00edguez Rdel","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/dkr464","article-title":"Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.","volume":"67","author":"Mint Lekweiry","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2010.140411-201409110919-R23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4269\/ajtmh.2008.78.217","article-title":"Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries.","volume":"78","author":"Rakotonirina","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2010.140411-201409110919-R24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1475-2875-11-295","article-title":"Performance of \u201cVIKIA Malaria Ag Pf\/Pan\u201d (IMACCESS\u00ae), a new malaria rapid diagnostic test for detection of symptomatic malaria infections.","volume":"11","author":"Chou","year":"2012","journal-title":"Malar J"},{"key":"key-10.3201\/eid2010.140411-201409110919-R25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/jac\/30.5.571","article-title":"Antimalarial drug resistance: the pace quickens.","volume":"30","author":"White","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2010.140411-201409110919-R26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3201\/eid1405.071601","article-title":"Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia\u2013Thailand border.","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2010.140411-201409110919-R27","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1128\/AAC.05280-11","article-title":"Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.","volume":"56","author":"Legrand","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2010.140411-201409110919-R28","first-page":"459","article-title":"Practical experience with mefloquine as an antimalarial","volume":"75","author":"Heimgartner","year":"1986","journal-title":"Schweiz Rundsch Med Prax"},{"key":"key-10.3201\/eid2010.140411-201409110919-R29","unstructured":"World Health Organization. International travel and health. Vaccination requirements and health advice. WHO Office of Information 1995 [cited 2014 Jul 30]. http:\/\/www.who.int\/ith\/en\/"},{"key":"key-10.3201\/eid2010.140411-201409110919-R30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/10\/14-0411_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:22:59Z","timestamp":1733268179000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/10\/14-0411_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2010.140411","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}